STAT

Eight midterm races putting pharma — and its influence — front and center

In West Virginia, the candidates for Senate are tussling over pharma again — plus seven other races where the drug industry is front and center.

WASHINGTON — A Republican political group is attempting to turn West Virginia’s race for Senate into a referendum over which candidate is more beholden to the pharmaceutical industry.

It is a bold strategy: Their own candidate, Republican nominee Patrick Morrisey, is a longtime pharmaceutical industry lobbyist.

Morrisey, the state’s attorney general, lobbied Capitol Hill in the early 2000s on behalf of drug makers including Celgene, Sanofi, and Novartis, according to a STAT review of lobbying disclosures. He has also lobbied on behalf of the Healthcare Distribution Alliance, the trade group representing the country’s major wholesalers. Those companies are now the subject of numerous lawsuits and investigations pertaining to their role in the opioid crisis.

The candidate’s deep ties to Big Pharma, however, have not deterred

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related